BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 12007221)

  • 41. Reduced response of Cystathionine Beta-Synthase (CBS) to S-Adenosylmethionine (SAM): Identification and functional analysis of CBS gene mutations in Homocystinuria patients.
    Mendes MI; Colaço HG; Smith DE; Ramos RJ; Pop A; van Dooren SJ; Tavares de Almeida I; Kluijtmans LA; Janssen MC; Rivera I; Salomons GS; Leandro P; Blom HJ
    J Inherit Metab Dis; 2014 Mar; 37(2):245-54. PubMed ID: 23974653
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cystathionine beta-synthase is coordinately regulated with proliferation through a redox-sensitive mechanism in cultured human cells and Saccharomyces cerevisiae.
    Maclean KN; Janosík M; Kraus E; Kozich V; Allen RH; Raab BK; Kraus JP
    J Cell Physiol; 2002 Jul; 192(1):81-92. PubMed ID: 12115739
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular genetic analysis of pyridoxine-nonresponsive homocystinuric siblings with different blood methionine levels during the neonatal period.
    Chen S; Ito M; Saijo T; Naito E; Kuroda Y
    J Med Invest; 1999 Aug; 46(3-4):186-91. PubMed ID: 10687314
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Correlation analysis between plasma homocysteine level and polymorphism of homocysteine metabolism related enzymes in ischemic cerebrovascular or cardiovascular diseases].
    Zhang G; Dai C
    Zhonghua Xue Ye Xue Za Zhi; 2002 Mar; 23(3):126-9. PubMed ID: 12015064
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Are heterocygotes for classical homocystinuria at risk of vitamin B12 and folic acid deficiency?
    Elsaid MF; Bener A; Lindner M; Alzyoud M; Shahbek N; Abdelrahman MO; Abdoh G; Bessisso MS; Zschocke J; Hoffmann GF
    Mol Genet Metab; 2007; 92(1-2):100-3. PubMed ID: 17686644
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vascular and connective tissue features in 5 Italian patients with homocystinuria.
    Evangelisti L; Lucarini L; Attanasio M; Porciani MC; Romano E; Prisco D; Gensini GF; Abbate R; Pepe G
    Int J Cardiol; 2009 May; 134(2):251-4. PubMed ID: 18280597
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of cystathionine beta-synthase gene mutations in homocystinuric Venezuelan patients: identification of one novel mutation in exon 6.
    De Lucca M; Casique L
    Mol Genet Metab; 2004 Mar; 81(3):209-15. PubMed ID: 14972327
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High prevalence of CBS p.T191M mutation in homocystinuric patients from Colombia.
    Bermúdez M; Frank N; Bernal J; Urreizti R; Briceño I; Merinero B; Perez-Cerdá C; Ugarte M; Grinberg D; Balcells S; Kraus JP
    Hum Mutat; 2006 Mar; 27(3):296. PubMed ID: 16470595
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Redox regulation and reaction mechanism of human cystathionine-beta-synthase: a PLP-dependent hemesensor protein.
    Banerjee R; Zou CG
    Arch Biochem Biophys; 2005 Jan; 433(1):144-56. PubMed ID: 15581573
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A pathogenic linked mutation in the catalytic core of human cystathionine beta-synthase disrupts allosteric regulation and allows kinetic characterization of a full-length dimer.
    Sen S; Banerjee R
    Biochemistry; 2007 Apr; 46(13):4110-6. PubMed ID: 17352495
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The cystathionine beta-synthase (CBS) mutation c.1224-2A>C in Central Europe: Vitamin B6 nonresponsiveness and a common ancestral haplotype.
    Linnebank M; Janosik M; Kozich V; Pronicka E; Kubalska J; Sokolova J; Linnebank A; Schmidt E; Leyendecker C; Klockgether T; Kraus JP; Koch HG
    Hum Mutat; 2004 Oct; 24(4):352-3. PubMed ID: 15365998
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Correction of cystathionine β-synthase deficiency in mice by treatment with proteasome inhibitors.
    Gupta S; Wang L; Anderl J; Slifker MJ; Kirk C; Kruger WD
    Hum Mutat; 2013 Aug; 34(8):1085-93. PubMed ID: 23592311
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification and functional analyses of CBS alleles in Spanish and Argentinian homocystinuric patients.
    Cozar M; Urreizti R; Vilarinho L; Grosso C; Dodelson de Kremer R; Asteggiano CG; Dalmau J; García AM; Vilaseca MA; Grinberg D; Balcells S
    Hum Mutat; 2011 Jul; 32(7):835-42. PubMed ID: 21520339
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of two pathogenic mutations in cystathionine beta-synthase: different intracellular locations for wild-type and mutant proteins.
    Casique L; Kabil O; Banerjee R; Martinez JC; De Lucca M
    Gene; 2013 Nov; 531(1):117-24. PubMed ID: 23981774
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Disease-causing cystathionine β-synthase linker mutations impair allosteric regulation.
    Roman JV; Mascarenhas R; Ceric K; Ballou DP; Banerjee R
    J Biol Chem; 2023 Dec; 299(12):105449. PubMed ID: 37949228
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Insights into the regulatory domain of cystathionine Beta-synthase: characterization of six variant proteins.
    Mendes MI; Santos AS; Smith DE; Lino PR; Colaço HG; de Almeida IT; Vicente JB; Salomons GS; Rivera I; Blom HJ; Leandro P
    Hum Mutat; 2014 Oct; 35(10):1195-202. PubMed ID: 25044645
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The molecular basis of cystathionine beta-synthase deficiency in Dutch patients with homocystinuria: effect of CBS genotype on biochemical and clinical phenotype and on response to treatment.
    Kluijtmans LA; Boers GH; Kraus JP; van den Heuvel LP; Cruysberg JR; Trijbels FJ; Blom HJ
    Am J Hum Genet; 1999 Jul; 65(1):59-67. PubMed ID: 10364517
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term betaine therapy in a murine model of cystathionine beta-synthase deficient homocystinuria: decreased efficacy over time reveals a significant threshold effect between elevated homocysteine and thrombotic risk.
    Maclean KN; Jiang H; Greiner LS; Allen RH; Stabler SP
    Mol Genet Metab; 2012 Mar; 105(3):395-403. PubMed ID: 22192524
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cystathionine beta-synthase null homocystinuric mice fail to exhibit altered hemostasis or lowering of plasma homocysteine in response to betaine treatment.
    Maclean KN; Sikora J; Kožich V; Jiang H; Greiner LS; Kraus E; Krijt J; Crnic LS; Allen RH; Stabler SP; Elleder M; Kraus JP
    Mol Genet Metab; 2010; 101(2-3):163-71. PubMed ID: 20638882
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Potential Pharmacological Chaperones for Cystathionine Beta-Synthase-Deficient Homocystinuria.
    Majtan T; Pey AL; Gimenez-Mascarell P; Martínez-Cruz LA; Szabo C; Kožich V; Kraus JP
    Handb Exp Pharmacol; 2018; 245():345-383. PubMed ID: 29119254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.